5 Key Takeaways

• 1

  The FDA approved Rayner's RayOne EMV Toric intraocular lens after a successful Investigational Device Exemption study.

• 2

  The lens aims to provide high-quality visual outcomes for patients with astigmatism.

• 3

  The pivotal trial enrolled 238 patients and demonstrated excellent rotational stability post-surgery.

• 4

  RayOne EMV Toric's optical design avoids light splitting technology, enhancing vision quality.

• 5

  Results showed at least 99% of eyes had lens rotation ≤5°, exceeding FDA requirements for stability.